Generic Platform
for the Multiplexed Targeted Electrochemical
Detection of Osteoporosis-Associated Single Nucleotide Polymorphisms
Using Recombinase Polymerase Solid-Phase Primer Elongation and Ferrocene-Modified
Nucleoside Triphosphates
posted on 2023-07-19, 12:08authored byMayreli Ortiz, Miriam Jauset-Rubio, Olivia Trummer, Ines Foessl, David Kodr, Josep Lluís Acero, Mary Luz Botero, Phil Biggs, Daniel Lenartowicz, Katerina Trajanoska, Fernando Rivadeneira, Michal Hocek, Barbara Obermayer-Pietsch, Ciara K. O’Sullivan
Osteoporosis is a
multifactorial disease influenced by genetic
and environmental factors, which contributes to an increased risk
of bone fracture, but early diagnosis of this disease cannot be achieved
using current techniques. We describe a generic platform for the targeted
electrochemical genotyping of SNPs identified by genome-wide association
studies to be associated with a genetic predisposition to osteoporosis.
The platform exploits isothermal solid-phase primer elongation with
ferrocene-labeled nucleoside triphosphates. Thiolated reverse primers
designed for each SNP were immobilized on individual gold electrodes
of an array. These primers are designed to hybridize to the SNP site
at their 3′OH terminal, and primer elongation occurs only where
there is 100% complementarity, facilitating the identification and
heterozygosity of each SNP under interrogation. The platform was applied
to real blood samples, which were thermally lysed and directly used
without the need for DNA extraction or purification. The results were
validated using Taqman SNP genotyping assays and Sanger sequencing.
The assay is complete in just 15 min with a total cost of 0.3€
per electrode. The platform is completely generic and has immense
potential for deployment at the point of need in an automated device
for targeted SNP genotyping with the only required end-user intervention
being sample addition.